Clinical Trials Logo

Post Prandial Distress Syndrome clinical trials

View clinical trials related to Post Prandial Distress Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT00673972 Withdrawn - Clinical trials for Functional Dyspepsia

Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome

Start date: April 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare postprandial distress syndrome and epigastric pain syndrome in demographics psychological features, infection of Helicobacter pylori, gastric emptying and therapeutic response to lansoprazole.

NCT ID: NCT00663897 Completed - Clinical trials for Functional Dyspepsia

Lansoprazole Versus Mosapride for Functional Dyspepsia

Start date: May 2008
Phase: Phase 4
Study type: Interventional

Functional dyspepsia is a common symptom complex with significant impact on quality of life. There is no standard treatment for functional dyspepsia but therapeutic efficacy of proton pump inhibitor (PPI) and prokinetic agent have been proved in subsets of patients. This study has two aims: - first is to compare the therapeutic efficacy of lansoprazole (a PPI) and mosapride (a prokinetic agent) for functional dyspepsia - second is to investigate whether different subgroups of functional dyspepsia (e.g., epigastric pain syndrome and postprandial distress syndrome) respond differently to PPI and prokinetic agent.

NCT ID: NCT00630370 Terminated - Clinical trials for Post Prandial Distress Syndrome

A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome

Start date: February 2008
Phase: Phase 2
Study type: Interventional

To assess the efficacy of 3 oral dosing regimens of ATI 7505 compared to placebo in patients with PDS by comparing at the end of Day 42 the percentage of patients in each treatment group who have had adequate relief of postprandial distress syndrome symptoms on at least 50% of the treatment days.